Marechale Capital (MAC) AI Stock Analysis

• Market Cap: £2.17M
• Dividend Yield: N/A
• Average Volume (3M): 194.68K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.59
• Revenue Growth: -15.42%
• EPS Growth: 53.66%
• Country: UK
• Employees: 4
• Sector: Financial
• Sector Strength: 71
• Industry: Financial - Capital Markets
• EPS (TTM): >-0.01
• Shares Outstanding: 105,941,246
• 10 Day Avg. Volume: 92,949
• 30 Day Avg. Volume: 194,679
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £1.50
• Price Target Upside: -26.83% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 56 Neutral
• Price Target: 1.50p ▼(-26.83% Downside)

Marechale Capital's overall score reflects its mixed financial health and strong technical momentum despite poor valuation metrics. The company's financial performance is hindered by profitability and liquidity issues. The technical indicators suggest positive momentum, but caution is advised due to potential overbought conditions. The valuation remains a significant concern, with negative earnings and no dividend yield.

Marechale Capital Business Overview & Revenue Model

Company Description

Marechale Capital (MAC) is a London-based corporate finance firm specializing in providing strategic advice and capital raising services to growth companies, particularly in the consumer brands, renewable energy, and technology sectors. The firm focuses on assisting companies in securing development capital, arranging equity and debt financing, and advising on mergers and acquisitions.

How the Company Makes Money

Marechale Capital makes money primarily through advisory fees and commissions earned from its corporate finance activities. The company charges fees for providing strategic advice and facilitating transactions, such as capital raising and mergers and acquisitions. These fees are typically structured as a percentage of the funds raised or the transaction value. Additionally, Marechale Capital may earn retainer fees for ongoing advisory services or from long-term partnerships with clients in its focus sectors.

Marechale Capital Financial Statement Overview

Summary

Marechale Capital shows mixed financial health. Despite strong revenue growth, the company struggles with profitability, as evidenced by negative margins and net losses. The balance sheet is robust due to low leverage, but cash flow challenges highlight liquidity concerns.

Income Statement

Marechale Capital's revenue growth has been inconsistent, with revenue increasing by 87.0% from 2023 to 2024 but decreasing in prior years. The gross profit margin for 2024 stands at 29.5%, indicating moderate profitability. However, the company has struggled with maintaining positive net income, as evidenced by a net profit margin of -27.4% in 2024. Furthermore, both EBIT and EBITDA margins have been negative, reflecting operational challenges.

Balance Sheet

The company's balance sheet shows strength in equity, with an equity ratio of 97.5% in 2024, indicating strong financial stability. The debt-to-equity ratio remains low at 0.007, suggesting minimal leverage and low risk from debt obligations. However, the return on equity is negative due to consistent net losses, undermining profitability and shareholder returns.

Cash Flow

Cash flow analysis reveals a challenging situation, with negative free cash flow in recent years. Despite an improvement in operating cash flow from -367,220 in 2023 to -256,063 in 2024, the company still faces difficulties in generating positive cash flow from operations. The operating cash flow to net income ratio indicates discrepancies between accounting income and cash generation, pointing to potential liquidity concerns.

Breakdown	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	668.82K	357.65K	621.57K	398.45K	475.25K
Gross Profit	197.38K	97.07K	329.94K	253.95K	420.66K
EBITDA	-182.56K	-52.12K	2.72M	246.96K	-2.12K
Net Income	-182.99K	-425.52K	2.56M	245.89K	-37.53K
Balance Sheet
Total Assets	3.43M	3.35M	3.73M	796.97K	272.14K
Cash, Cash Equivalents and Short-Term Investments	3.29M	3.15M	3.54M	656.36K	209.27K
Total Debt	22.50K	32.50K	42.50K	50.00K	0.00
Total Liabilities	84.53K	124.06K	99.87K	111.21K	113.52K
Stockholders Equity	3.35M	3.23M	3.63M	685.75K	158.62K
Cash Flow
Free Cash Flow	-256.06K	-367.22K	-131.85K	-92.51K	-63.33K
Operating Cash Flow	-256.06K	-367.22K	-131.85K	-191.79K	-15.14K
Investing Cash Flow	-3.64K	226.93K	-42.46K	-49.65K	24.07K
Financing Cash Flow	225.10K	-8.42K	355.00K	317.49K	-296.00

Marechale Capital Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2.05
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:MAC, the sentiment is Positive. The current price of 2.05 is above the 20-day moving average (MA) of 2.03, above the 50-day MA of 2.04, and above the 200-day MA of 1.67, indicating a bullish trend. The MACD of 0.01 indicates Positive momentum. The RSI at 51.28 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:MAC.

Marechale Capital Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FKE	74 Outperform	£8.27M	6.45	13.07%	1.46%	16.60%	117.20%
Sector *	65 Neutral	£5.45B	8.77	9.49%	5.11%	10.05%	-13.15%
MAC	56 Neutral	£2.17M	―	-6.30%	―	-15.42%	53.66%
CAV	56 Neutral	£45.67M	55.68	1.93%	4.49%	15.72%	―
WHI	42 Neutral	£5.12M	―		―	―	―

Marechale Capital Corporate Events

Marechale Capital Issues Options to Non-Executive Director

Marechale Capital has announced the issuance of 250,000 options over Ordinary Shares to Chris Kenning, a Non-executive Director, as payment for director fees. This move reflects the company’s strategy to manage its financial obligations through equity-based compensation, potentially influencing its share capital structure and stakeholder interests. The options, representing 0.24% of the issued share capital, have a vesting period of three years, aligning with Marechale’s long-term growth and investment strategies.